New study into COVID-19 vaccine dose interval for pregnant women

New study into COVID-19 vaccine dose interval for pregnant women The country’s largest clinical trial investigating the best gap between first and second COVID-19 vaccine doses for pregnant women is being launched in England.

Following 130,000 pregnant women being vaccinated in the US and no safety concerns being raised, the Pfizer/BioNTech and Moderna vaccines were recommended by the independent experts at the Joint Committee on Vaccination and Immunisation (JCVI) for pregnant women in the UK. Almost 52,000 pregnant women in England have now been vaccinated – similarly, with no safety concerns reported. Department of Health and Social Care

See also: 

• NHS COVID-19 app updated to notify fewer contacts to isolate Department of Health and Social Care
• More than 85 million COVID-19 vaccines administered in UK Department of Health and Social Care
• Chief midwife urges pregnant women to get NHS COVID jab NHS England
• COVID-19 vaccine surveillance report published Public Health England